Progyny, Inc. (PGNY) stock forecast and price target
Price $36.18 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($36.18)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $2.11 | +11.8% | $1.4B |
| Next fiscal year ends December 31, 2027 | $2.40 | +13.7% | $1.5B |
| Next quarter ends December 31, 2026 | $0.54 | +13.3% | $357M |
| Quarter after ends March 31, 2027 | $0.57 | +14.6% | $367M |
Consensus of the analysts covering Progyny, updated daily. In the last 30 days 5 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 3.0% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Progyny’s intrinsic value about 20% above today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Progyny stock price target?
The average 12-month target from 12 analysts is $37.25, 3.0% above the current price of $36.18 Targets range from $35.00 to $40.00.
Is Progyny a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 9 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Progyny expected to earn?
Analysts expect EPS of $2.11 for the fiscal year ending December 31, 2026 and $2.40 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.